4//SEC Filing
Morris Chanan 4
Accession 0001178913-18-000894
CIK 0001062128other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:15 PM ET
Size
5.7 KB
Accession
0001178913-18-000894
Insider Transaction Report
Form 4
Morris Chanan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-15+50,000→ 50,000 totalExercise: $1.30Exp: 2028-03-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option, representing a right to purchase 50,000 shares of the Issuer's common stock at an exercise price of $1.30 per share, vests ratably over a 48 month period commencing on the first day of the month beginning on February 1, 2018.
Documents
Issuer
Artemis Therapeutics, Inc.
CIK 0001062128
Entity typeother
Related Parties
1- filerCIK 0001621439
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:15 PM ET
- Size
- 5.7 KB